Europe Bioreactors Market Forecast to 2030 - Regional Analysis - by Scale (Lab-Scale Production, Pilot-Scale Production, and Full-Scale Production), Application (Microbial Application, Cell Culture Application, and Others), Technology (Fed-Batch Bioreactors and Perfusion Bioreactors), and End User (Biopharma Manufacturers, Research and Development Organizations, and Contract Manufacturing Organization)
The Europe bioreactors market was valued at US$ 919.86 million in 2022 and is expected to reach US$ 1,732.95 million by 2030; it is estimated to grow at a CAGR of 8.2% from 2022 to 2030.
Rising Demand for Personalized Medicine Drives Europe Bioreactors Market
The transformation of the healthcare industry from one-size-fits-all to a targeted approach is expanding the demand for personalized medicine. Precision medicine is being considered as one of the most promising approaches to tackle diseases such as cancer, neurodegenerative diseases, and rare genetic conditions. Innovations in the production of personalized medicines are likely to impact the entire sector, and single-use technologies aimed at smaller-volume production have potential applications in protein bioproduction, particularly in downstream processes. Personalized and differentiated approaches to medicine are leading to a need for a wider range of products, many of them for a relatively small number of patients. A fundamentally different approach to the production and delivery of biological products may be required.
Precision medicine utilizes the genomic information of an individual to offer targeted treatment for a particular indication. The rising prevalence of a number of chronic diseases has increased the demand for biologics, drugs for orphan diseases, and personalized medicines. For instance, in 2019, the FDA approved 12 personalized medications to address the root causes of disease and further integrate precision medicine with clinical care.
Europe Bioreactors Market Overview
In Germany, new product development, extensive research & development activities in pharmaceutical and biotechnology companies, and the growth of biologics and life sciences drive the market growth. In August 2023, Sartorius, one of the leading suppliers for the biopharmaceutical industry, collaborated with global technology and software leader Emerson to integrate Sartorius's Biostat STR Generation 3 family of bioreactors with Emerson's DeltaVTM distributed control system (DCS). The biotechnology sector in Germany exhibits tremendous growth owing to the presence of numerous biotechnology companies, high-tech research labs, and massive funding for research and development. Moreover, the cutting-edge and high-quality research in the country and the presence of an established market for bioreactors creates lucrative opportunities. The growth of research and development in biopharmaceuticals and biologics is majorly driven by the adoption of various organic strategies by companies in the healthcare industry. For instance, in June 2021, Rentschler Biopharma expanded its production capacity with a 2,000-liter bioreactor to address the increasing demand for complex antibodies, a class of biopharmaceutical drugs with continued high potential. The pharmaceutical sector in the country is growing due to increasing R&D expenditure by pharmaceutical companies. Thus, collaborative research efforts by pharmaceutical and biotechnology companies in the country influence the market.
Europe Bioreactors Market Revenue and Forecast to 2030 (US$ Million)
Europe Bioreactors Market Segmentation
The Europe bioreactors market is segmented based on scale, application, technology, end user, and country. Based on scale, the Europe bioreactors market is segmented into lab-scale production, pilot-scale production, and full-scale production. The pilot-scale production segment held the largest market share in 2022.
In terms of application, the Europe bioreactors market is categorized into microbial application, cell culture application, and others. The cell culture application segment held the largest market share in 2022.
By technology, the Europe bioreactors market is bifurcated into fed-batch bioreactors and perfusion bioreactors. The fed-batch bioreactors segment held a larger market share in 2022.
Based on end user, the Europe bioreactors market is categorized into biopharma manufacturers, research and development organizations, and contract manufacturing organization. The research and development organizations segment held the largest market share in 2022.
Based on country, the Europe bioreactors market is segmented into Germany, France, Italy, the UK, Spain, and the Rest of Europe. Germany dominated the Europe bioreactors market share in 2022.
Applikon Biotechnology BV, bbi-biotech GmbH, Cellexus International Ltd, General Electric Co, Merck KGaA, Pall Corp, PBS Biotech Inc, Sartorius AG, Solaris Biotechnology SRL, and Thermo Fisher Scientific Inc are some of the leading players operating in the Europe bioreactors market.
Rising Demand for Personalized Medicine Drives Europe Bioreactors Market
The transformation of the healthcare industry from one-size-fits-all to a targeted approach is expanding the demand for personalized medicine. Precision medicine is being considered as one of the most promising approaches to tackle diseases such as cancer, neurodegenerative diseases, and rare genetic conditions. Innovations in the production of personalized medicines are likely to impact the entire sector, and single-use technologies aimed at smaller-volume production have potential applications in protein bioproduction, particularly in downstream processes. Personalized and differentiated approaches to medicine are leading to a need for a wider range of products, many of them for a relatively small number of patients. A fundamentally different approach to the production and delivery of biological products may be required.
Precision medicine utilizes the genomic information of an individual to offer targeted treatment for a particular indication. The rising prevalence of a number of chronic diseases has increased the demand for biologics, drugs for orphan diseases, and personalized medicines. For instance, in 2019, the FDA approved 12 personalized medications to address the root causes of disease and further integrate precision medicine with clinical care.
Europe Bioreactors Market Overview
In Germany, new product development, extensive research & development activities in pharmaceutical and biotechnology companies, and the growth of biologics and life sciences drive the market growth. In August 2023, Sartorius, one of the leading suppliers for the biopharmaceutical industry, collaborated with global technology and software leader Emerson to integrate Sartorius's Biostat STR Generation 3 family of bioreactors with Emerson's DeltaVTM distributed control system (DCS). The biotechnology sector in Germany exhibits tremendous growth owing to the presence of numerous biotechnology companies, high-tech research labs, and massive funding for research and development. Moreover, the cutting-edge and high-quality research in the country and the presence of an established market for bioreactors creates lucrative opportunities. The growth of research and development in biopharmaceuticals and biologics is majorly driven by the adoption of various organic strategies by companies in the healthcare industry. For instance, in June 2021, Rentschler Biopharma expanded its production capacity with a 2,000-liter bioreactor to address the increasing demand for complex antibodies, a class of biopharmaceutical drugs with continued high potential. The pharmaceutical sector in the country is growing due to increasing R&D expenditure by pharmaceutical companies. Thus, collaborative research efforts by pharmaceutical and biotechnology companies in the country influence the market.
Europe Bioreactors Market Revenue and Forecast to 2030 (US$ Million)
Europe Bioreactors Market Segmentation
The Europe bioreactors market is segmented based on scale, application, technology, end user, and country. Based on scale, the Europe bioreactors market is segmented into lab-scale production, pilot-scale production, and full-scale production. The pilot-scale production segment held the largest market share in 2022.
In terms of application, the Europe bioreactors market is categorized into microbial application, cell culture application, and others. The cell culture application segment held the largest market share in 2022.
By technology, the Europe bioreactors market is bifurcated into fed-batch bioreactors and perfusion bioreactors. The fed-batch bioreactors segment held a larger market share in 2022.
Based on end user, the Europe bioreactors market is categorized into biopharma manufacturers, research and development organizations, and contract manufacturing organization. The research and development organizations segment held the largest market share in 2022.
Based on country, the Europe bioreactors market is segmented into Germany, France, Italy, the UK, Spain, and the Rest of Europe. Germany dominated the Europe bioreactors market share in 2022.
Applikon Biotechnology BV, bbi-biotech GmbH, Cellexus International Ltd, General Electric Co, Merck KGaA, Pall Corp, PBS Biotech Inc, Sartorius AG, Solaris Biotechnology SRL, and Thermo Fisher Scientific Inc are some of the leading players operating in the Europe bioreactors market.
1. INTRODUCTION
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. EXECUTIVE SUMMARY
2.1 Key Insights
3. RESEARCH METHODOLOGY
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. EUROPE BIOREACTORS MARKET - KEY INDUSTRY DYNAMICS
4.1 Bioreactors Market - Key Industry Dynamics
4.2 Market Drivers
4.2.1 Increasing Adoption of Single-Use Bioreactors
4.2.2 Rapid Growth of Pharmaceutical and Biotechnology Industry
4.3 Market Restraints
4.3.1 Stringent Regulatory Framework
4.4 Market Opportunities
4.4.1 Rising Demand for Personalized Medicine
4.5 Future Trends
4.5.1 Technological Advancements in Bioreactors
4.6 Impact of Drivers and Restraints:
5. BIOREACTORS MARKET - EUROPE MARKET ANALYSIS
5.1 Overview
5.1.1 Bioreactors Market Revenue (US$ Million), 2020 – 2030
6. EUROPE BIOREACTORS MARKET ANALYSIS - SCALE
6.1 Overview
6.2 Bioreactors Market Revenue Share, by Scale 2022 & 2030 (%)
6.3 Lab-Scale Production
6.3.1 Overview
6.3.2 Lab-Scale Production Market, Revenue and Forecast to 2030 (US$ Million)
6.4 Pilot-Scale Production
6.4.1 Overview
6.4.2 Pilot-Scale Production Market, Revenue and Forecast to 2030 (US$ Million)
6.5 Full-Scale Production
6.5.1 Overview
6.5.2 Full-Scale Production Market, Revenue and Forecast to 2030 (US$ Million)
7. EUROPE BIOREACTORS MARKET ANALYSIS - APPLICATION
7.1 Overview
7.2 Bioreactors Market Revenue Share, by Application 2022 & 2030 (%)
7.3 Microbial Application
7.3.1 Overview
7.3.2 Microbial Application Market, Revenue and Forecast to 2030 (US$ Million)
7.4 Cell Culture Application
7.4.1 Overview
7.4.2 Cell Culture Application Market, Revenue and Forecast to 2030 (US$ Million)
7.5 Others
7.5.1 Overview
7.5.2 Others Market, Revenue and Forecast to 2030 (US$ Million)
8. EUROPE BIOREACTORS MARKET ANALYSIS - TECHNOLOGY
8.1 Overview
8.2 Bioreactors Market Revenue Share, by Technology 2022 & 2030 (%)
8.3 Fed-Batch Bioreactors
8.3.1 Overview
8.3.2 Fed-Batch Bioreactors Market, Revenue and Forecast to 2030 (US$ Million)
8.4 Perfusion Bioreactors
8.4.1 Overview
8.4.2 Perfusion Bioreactors Market, Revenue and Forecast to 2030 (US$ Million)
9. EUROPE BIOREACTORS MARKET ANALYSIS - END USER
9.1 Overview
9.2 Bioreactors Market Revenue Share, by End User 2022 & 2030 (%)
9.3 Biopharma Manufacturers
9.3.1 Overview
9.3.2 Biopharma Manufacturers Market, Revenue and Forecast to 2030 (US$ Million)
9.4 Research and Development Organizations
9.4.1 Overview
9.4.2 Research and Development Organizations Market, Revenue and Forecast to 2030 (US$ Million)
9.5 Contract Manufacturing Organization
9.5.1 Overview
9.5.2 Contract Manufacturing Organization Market, Revenue and Forecast to 2030 (US$ Million)
10. EUROPE BIOREACTORS MARKET – BY COUNTRY ANALYSIS
10.1 Europe: Bioreactors Market
10.1.1 Europe Bioreactors Market Revenue and Forecasts and Analysis - By Country
10.1.1.1 Germany
10.1.1.2 Overview
10.1.1.3 Germany: Bioreactors Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.3.1 Germany Bioreactors Market Breakdown by Scale
10.1.1.3.2 Germany Bioreactors Market Breakdown by Application
10.1.1.3.3 Germany Bioreactors Market Breakdown by Technology
10.1.1.3.4 Germany Bioreactors Market Breakdown by End User
10.1.1.4 France
10.1.1.5 Overview
10.1.1.6 France: Bioreactors Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.6.1 France Bioreactors Market Breakdown by Scale
10.1.1.6.2 France Bioreactors Market Breakdown by Application
10.1.1.6.3 France Bioreactors Market Breakdown by Technology
10.1.1.6.4 France Bioreactors Market Breakdown by End User
10.1.1.7 UK
10.1.1.8 Overview
10.1.1.9 UK: Bioreactors Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.9.1 UK Bioreactors Market Breakdown by Scale
10.1.1.9.2 UK Bioreactors Market Breakdown by Application
10.1.1.9.3 UK Bioreactors Market Breakdown by Technology
10.1.1.9.4 UK Bioreactors Market Breakdown by End User
10.1.1.10 Italy
10.1.1.11 Overview
10.1.1.12 Italy: Bioreactors Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.12.1 Italy Bioreactors Market Breakdown by Scale
10.1.1.12.2 Italy Bioreactors Market Breakdown by Application
10.1.1.12.3 Italy Bioreactors Market Breakdown by Technology
10.1.1.12.4 Italy Bioreactors Market Breakdown by End User
10.1.1.13 Spain
10.1.1.14 Overview
10.1.1.15 Spain: Bioreactors Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.15.1 Spain Bioreactors Market Breakdown by Scale
10.1.1.15.2 Spain Bioreactors Market Breakdown by Application
10.1.1.15.3 Spain Bioreactors Market Breakdown by Technology
10.1.1.15.4 Spain Bioreactors Market Breakdown by End User
10.1.1.16 Rest of Europe
10.1.1.17 Overview
10.1.1.18 Rest of Europe: Bioreactors Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.18.1 Rest of Europe Bioreactors Market Breakdown by Scale
10.1.1.18.2 Rest of Europe Bioreactors Market Breakdown by Application
10.1.1.18.3 Rest of Europe Bioreactors Market Breakdown by Technology
10.1.1.18.4 Rest of Europe Bioreactors Market Breakdown by End User
11. BIOREACTORS MARKET-INDUSTRY LANDSCAPE
11.1 Overview
11.2 Growth Strategies in the Bioreactors Market
11.3 Inorganic Growth Strategies
11.3.1 Overview
11.4 Organic Growth Strategies
11.4.1 Overview
12. COMPANY PROFILES
12.1 PBS Biotech Inc
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Cellexus International Ltd
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 General Electric Co
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Merck KGaA
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Thermo Fisher Scientific Inc
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 bbi-biotech GmbH
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 SWOT Analysis
12.6.5 Key Developments
12.7 Sartorius AG
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Pall Corp
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Solaris Biotechnology SRL
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Applikon Biotechnology BV
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. APPENDIX
13.1 About The Insight Partners
13.2 Glossary of Terms
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. EXECUTIVE SUMMARY
2.1 Key Insights
3. RESEARCH METHODOLOGY
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. EUROPE BIOREACTORS MARKET - KEY INDUSTRY DYNAMICS
4.1 Bioreactors Market - Key Industry Dynamics
4.2 Market Drivers
4.2.1 Increasing Adoption of Single-Use Bioreactors
4.2.2 Rapid Growth of Pharmaceutical and Biotechnology Industry
4.3 Market Restraints
4.3.1 Stringent Regulatory Framework
4.4 Market Opportunities
4.4.1 Rising Demand for Personalized Medicine
4.5 Future Trends
4.5.1 Technological Advancements in Bioreactors
4.6 Impact of Drivers and Restraints:
5. BIOREACTORS MARKET - EUROPE MARKET ANALYSIS
5.1 Overview
5.1.1 Bioreactors Market Revenue (US$ Million), 2020 – 2030
6. EUROPE BIOREACTORS MARKET ANALYSIS - SCALE
6.1 Overview
6.2 Bioreactors Market Revenue Share, by Scale 2022 & 2030 (%)
6.3 Lab-Scale Production
6.3.1 Overview
6.3.2 Lab-Scale Production Market, Revenue and Forecast to 2030 (US$ Million)
6.4 Pilot-Scale Production
6.4.1 Overview
6.4.2 Pilot-Scale Production Market, Revenue and Forecast to 2030 (US$ Million)
6.5 Full-Scale Production
6.5.1 Overview
6.5.2 Full-Scale Production Market, Revenue and Forecast to 2030 (US$ Million)
7. EUROPE BIOREACTORS MARKET ANALYSIS - APPLICATION
7.1 Overview
7.2 Bioreactors Market Revenue Share, by Application 2022 & 2030 (%)
7.3 Microbial Application
7.3.1 Overview
7.3.2 Microbial Application Market, Revenue and Forecast to 2030 (US$ Million)
7.4 Cell Culture Application
7.4.1 Overview
7.4.2 Cell Culture Application Market, Revenue and Forecast to 2030 (US$ Million)
7.5 Others
7.5.1 Overview
7.5.2 Others Market, Revenue and Forecast to 2030 (US$ Million)
8. EUROPE BIOREACTORS MARKET ANALYSIS - TECHNOLOGY
8.1 Overview
8.2 Bioreactors Market Revenue Share, by Technology 2022 & 2030 (%)
8.3 Fed-Batch Bioreactors
8.3.1 Overview
8.3.2 Fed-Batch Bioreactors Market, Revenue and Forecast to 2030 (US$ Million)
8.4 Perfusion Bioreactors
8.4.1 Overview
8.4.2 Perfusion Bioreactors Market, Revenue and Forecast to 2030 (US$ Million)
9. EUROPE BIOREACTORS MARKET ANALYSIS - END USER
9.1 Overview
9.2 Bioreactors Market Revenue Share, by End User 2022 & 2030 (%)
9.3 Biopharma Manufacturers
9.3.1 Overview
9.3.2 Biopharma Manufacturers Market, Revenue and Forecast to 2030 (US$ Million)
9.4 Research and Development Organizations
9.4.1 Overview
9.4.2 Research and Development Organizations Market, Revenue and Forecast to 2030 (US$ Million)
9.5 Contract Manufacturing Organization
9.5.1 Overview
9.5.2 Contract Manufacturing Organization Market, Revenue and Forecast to 2030 (US$ Million)
10. EUROPE BIOREACTORS MARKET – BY COUNTRY ANALYSIS
10.1 Europe: Bioreactors Market
10.1.1 Europe Bioreactors Market Revenue and Forecasts and Analysis - By Country
10.1.1.1 Germany
10.1.1.2 Overview
10.1.1.3 Germany: Bioreactors Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.3.1 Germany Bioreactors Market Breakdown by Scale
10.1.1.3.2 Germany Bioreactors Market Breakdown by Application
10.1.1.3.3 Germany Bioreactors Market Breakdown by Technology
10.1.1.3.4 Germany Bioreactors Market Breakdown by End User
10.1.1.4 France
10.1.1.5 Overview
10.1.1.6 France: Bioreactors Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.6.1 France Bioreactors Market Breakdown by Scale
10.1.1.6.2 France Bioreactors Market Breakdown by Application
10.1.1.6.3 France Bioreactors Market Breakdown by Technology
10.1.1.6.4 France Bioreactors Market Breakdown by End User
10.1.1.7 UK
10.1.1.8 Overview
10.1.1.9 UK: Bioreactors Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.9.1 UK Bioreactors Market Breakdown by Scale
10.1.1.9.2 UK Bioreactors Market Breakdown by Application
10.1.1.9.3 UK Bioreactors Market Breakdown by Technology
10.1.1.9.4 UK Bioreactors Market Breakdown by End User
10.1.1.10 Italy
10.1.1.11 Overview
10.1.1.12 Italy: Bioreactors Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.12.1 Italy Bioreactors Market Breakdown by Scale
10.1.1.12.2 Italy Bioreactors Market Breakdown by Application
10.1.1.12.3 Italy Bioreactors Market Breakdown by Technology
10.1.1.12.4 Italy Bioreactors Market Breakdown by End User
10.1.1.13 Spain
10.1.1.14 Overview
10.1.1.15 Spain: Bioreactors Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.15.1 Spain Bioreactors Market Breakdown by Scale
10.1.1.15.2 Spain Bioreactors Market Breakdown by Application
10.1.1.15.3 Spain Bioreactors Market Breakdown by Technology
10.1.1.15.4 Spain Bioreactors Market Breakdown by End User
10.1.1.16 Rest of Europe
10.1.1.17 Overview
10.1.1.18 Rest of Europe: Bioreactors Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.18.1 Rest of Europe Bioreactors Market Breakdown by Scale
10.1.1.18.2 Rest of Europe Bioreactors Market Breakdown by Application
10.1.1.18.3 Rest of Europe Bioreactors Market Breakdown by Technology
10.1.1.18.4 Rest of Europe Bioreactors Market Breakdown by End User
11. BIOREACTORS MARKET-INDUSTRY LANDSCAPE
11.1 Overview
11.2 Growth Strategies in the Bioreactors Market
11.3 Inorganic Growth Strategies
11.3.1 Overview
11.4 Organic Growth Strategies
11.4.1 Overview
12. COMPANY PROFILES
12.1 PBS Biotech Inc
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Cellexus International Ltd
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 General Electric Co
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Merck KGaA
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Thermo Fisher Scientific Inc
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 bbi-biotech GmbH
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 SWOT Analysis
12.6.5 Key Developments
12.7 Sartorius AG
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Pall Corp
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Solaris Biotechnology SRL
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Applikon Biotechnology BV
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. APPENDIX
13.1 About The Insight Partners
13.2 Glossary of Terms
